Lexington Biosciences, Inc. (LXGTF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Lexington Biosciences, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.02
Earnings Deficit
P/B Ratio
-0.00
Equity Deficit
Earnings Yield
-75.53%
Yield Gap
Profitability Health
2023Return on Equity
17.94%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
2023Revenue Growth
-
No data
Net Income Growth
-101261.14%
Weak
WeakModerateStrong
EPS Growth
-1.56%
Weak
WeakModerateStrong
Efficiency & Liquidity
2023Current Ratio
-
No data
Quick Ratio
-
No data
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-
No data
EV / Free Cash Flow
-
No data
Net Debt / EBITDA
0.00x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.120
Strong
WeakModerateStrong
Return on Invested Capital
15.98%
Moderate
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for LXGTF.
View Financial Statements